MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI
Identifieur interne : 000181 ( Pmc/Curation ); précédent : 000180; suivant : 000182MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI
Auteurs : I. Litvan [États-Unis] ; D. Aarsland ; Ch Adler [États-Unis] ; Jg Goldman [États-Unis] ; J. Kulisevsky [Espagne] ; B. Mollenhauer [Allemagne] ; Mc Rodriguez-Oroz [Espagne] ; Ai Tröster [États-Unis] ; D. Weintraub [États-Unis]Source :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2011.
Abstract
There is controversy regarding the definition and characteristics of mild cognitive impairment in Parkinson’s disease.
The Movement Disorders Society commissioned a Task Force to critically evaluate the literature and determine the frequency and characteristics of Parkinson’s disease-mild cognitive impairment and its association with dementia.
Comprehensive PubMed literature review using systematic inclusion and exclusion criteria.
A mean of 26.7% (range, 18.9–38.2%) of non-demented Parkinson’s disease patients have mild cognitive impairment. The frequency of Parkinson’s disease mild cognitive impairment increases with age, disease duration, and disease severity. Impairments occur in a range of cognitive domains, but single domain impairment is more common than multiple domain impairment, and within single domain impairment, non-amnestic is more common than amnestic impairment. A high proportion of patients with Parkinson’s disease-mild cognitive impairment progress to dementia in a relatively short period of time.
The primary conclusions of the Task Force are that: (1) Parkinson’s disease-mild cognitive impairment is common; (2) there is significant heterogeneity within Parkinson’s disease-mild cognitive impairment in the number and types of cognitive domain impairments; (3) Parkinson’s disease-mild cognitive impairment appears to place patients at risk of progressing to dementia; and (4) formal diagnostic criteria for Parkinson’s disease-mild cognitive impairment are needed.
Url:
DOI: 10.1002/mds.23823
PubMed: 21661055
PubMed Central: 3181006
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000181
Links to Exploration step
PMC:3181006Curation
No country items
D. Aarsland<affiliation><nlm:aff id="A2"> Centre for Age-Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo</nlm:aff>
<wicri:noCountry code="subfield">Stavanger University Hospital and Akershus University Hospital/University of Oslo</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI</title>
<author><name sortKey="Litvan, I" sort="Litvan, I" uniqKey="Litvan I" first="I" last="Litvan">I. Litvan</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY, USA and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, KY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Kentucky</region>
</placeName>
<wicri:cityArea> Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY, USA and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Aarsland, D" sort="Aarsland, D" uniqKey="Aarsland D" first="D" last="Aarsland">D. Aarsland</name>
<affiliation><nlm:aff id="A2"> Centre for Age-Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo</nlm:aff>
<wicri:noCountry code="subfield">Stavanger University Hospital and Akershus University Hospital/University of Oslo</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Adler, Ch" sort="Adler, Ch" uniqKey="Adler C" first="Ch" last="Adler">Ch Adler</name>
<affiliation wicri:level="1"><nlm:aff id="A3"> Parkinson’s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Parkinson’s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Goldman, Jg" sort="Goldman, Jg" uniqKey="Goldman J" first="Jg" last="Goldman">Jg Goldman</name>
<affiliation wicri:level="1"><nlm:aff id="A4"> Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kulisevsky, J" sort="Kulisevsky, J" uniqKey="Kulisevsky J" first="J" last="Kulisevsky">J. Kulisevsky</name>
<affiliation wicri:level="1"><nlm:aff id="A5"> Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea> Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mollenhauer, B" sort="Mollenhauer, B" uniqKey="Mollenhauer B" first="B" last="Mollenhauer">B. Mollenhauer</name>
<affiliation wicri:level="1"><nlm:aff id="A6"> Paracelsus-Elena-Klinik, Kassel and Georg-August University Goettingen, Germany</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea> Paracelsus-Elena-Klinik, Kassel and Georg-August University Goettingen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rodriguez Oroz, Mc" sort="Rodriguez Oroz, Mc" uniqKey="Rodriguez Oroz M" first="Mc" last="Rodriguez-Oroz">Mc Rodriguez-Oroz</name>
<affiliation wicri:level="1"><nlm:aff id="A7"> Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea> Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Troster, Ai" sort="Troster, Ai" uniqKey="Troster A" first="Ai" last="Tröster">Ai Tröster</name>
<affiliation wicri:level="1"><nlm:aff id="A8"> Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Weintraub, D" sort="Weintraub, D" uniqKey="Weintraub D" first="D" last="Weintraub">D. Weintraub</name>
<affiliation wicri:level="1"><nlm:aff id="A9"> Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine; Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine; Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">21661055</idno>
<idno type="pmc">3181006</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181006</idno>
<idno type="RBID">PMC:3181006</idno>
<idno type="doi">10.1002/mds.23823</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000181</idno>
<idno type="wicri:Area/Pmc/Curation">000181</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI</title>
<author><name sortKey="Litvan, I" sort="Litvan, I" uniqKey="Litvan I" first="I" last="Litvan">I. Litvan</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY, USA and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, KY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Kentucky</region>
</placeName>
<wicri:cityArea> Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY, USA and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Aarsland, D" sort="Aarsland, D" uniqKey="Aarsland D" first="D" last="Aarsland">D. Aarsland</name>
<affiliation><nlm:aff id="A2"> Centre for Age-Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo</nlm:aff>
<wicri:noCountry code="subfield">Stavanger University Hospital and Akershus University Hospital/University of Oslo</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Adler, Ch" sort="Adler, Ch" uniqKey="Adler C" first="Ch" last="Adler">Ch Adler</name>
<affiliation wicri:level="1"><nlm:aff id="A3"> Parkinson’s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Parkinson’s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Goldman, Jg" sort="Goldman, Jg" uniqKey="Goldman J" first="Jg" last="Goldman">Jg Goldman</name>
<affiliation wicri:level="1"><nlm:aff id="A4"> Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kulisevsky, J" sort="Kulisevsky, J" uniqKey="Kulisevsky J" first="J" last="Kulisevsky">J. Kulisevsky</name>
<affiliation wicri:level="1"><nlm:aff id="A5"> Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea> Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mollenhauer, B" sort="Mollenhauer, B" uniqKey="Mollenhauer B" first="B" last="Mollenhauer">B. Mollenhauer</name>
<affiliation wicri:level="1"><nlm:aff id="A6"> Paracelsus-Elena-Klinik, Kassel and Georg-August University Goettingen, Germany</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea> Paracelsus-Elena-Klinik, Kassel and Georg-August University Goettingen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rodriguez Oroz, Mc" sort="Rodriguez Oroz, Mc" uniqKey="Rodriguez Oroz M" first="Mc" last="Rodriguez-Oroz">Mc Rodriguez-Oroz</name>
<affiliation wicri:level="1"><nlm:aff id="A7"> Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea> Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Troster, Ai" sort="Troster, Ai" uniqKey="Troster A" first="Ai" last="Tröster">Ai Tröster</name>
<affiliation wicri:level="1"><nlm:aff id="A8"> Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Weintraub, D" sort="Weintraub, D" uniqKey="Weintraub D" first="D" last="Weintraub">D. Weintraub</name>
<affiliation wicri:level="1"><nlm:aff id="A9"> Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine; Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine; Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title>
<p id="P1">There is controversy regarding the definition and characteristics of mild cognitive impairment in Parkinson’s disease.</p>
</sec>
<sec id="S2"><title>Objective</title>
<p id="P2">The Movement Disorders Society commissioned a Task Force to critically evaluate the literature and determine the frequency and characteristics of Parkinson’s disease-mild cognitive impairment and its association with dementia.</p>
</sec>
<sec sec-type="methods" id="S3"><title>Methods</title>
<p id="P3">Comprehensive PubMed literature review using systematic inclusion and exclusion criteria.</p>
</sec>
<sec id="S4"><title>Results</title>
<p id="P4">A mean of 26.7% (range, 18.9–38.2%) of non-demented Parkinson’s disease patients have mild cognitive impairment. The frequency of Parkinson’s disease mild cognitive impairment increases with age, disease duration, and disease severity. Impairments occur in a range of cognitive domains, but single domain impairment is more common than multiple domain impairment, and within single domain impairment, non-amnestic is more common than amnestic impairment. A high proportion of patients with Parkinson’s disease-mild cognitive impairment progress to dementia in a relatively short period of time.</p>
</sec>
<sec id="S5"><title>Conclusions</title>
<p id="P5">The primary conclusions of the Task Force are that: (1) Parkinson’s disease-mild cognitive impairment is common; (2) there is significant heterogeneity within Parkinson’s disease-mild cognitive impairment in the number and types of cognitive domain impairments; (3) Parkinson’s disease-mild cognitive impairment appears to place patients at risk of progressing to dementia; and (4) formal diagnostic criteria for Parkinson’s disease-mild cognitive impairment are needed.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article" xml:lang="en"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">8610688</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5937</journal-id>
<journal-id journal-id-type="nlm-ta">Mov Disord</journal-id>
<journal-title-group><journal-title>Movement disorders : official journal of the Movement Disorder Society</journal-title>
</journal-title-group>
<issn pub-type="ppub">0885-3185</issn>
<issn pub-type="epub">1531-8257</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">21661055</article-id>
<article-id pub-id-type="pmc">3181006</article-id>
<article-id pub-id-type="doi">10.1002/mds.23823</article-id>
<article-id pub-id-type="manuscript">NIHMS296543</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Litvan</surname>
<given-names>I</given-names>
</name>
<xref rid="A1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Aarsland</surname>
<given-names>D</given-names>
</name>
<xref rid="A2" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Adler</surname>
<given-names>CH</given-names>
</name>
<xref rid="A3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Goldman</surname>
<given-names>JG</given-names>
</name>
<xref rid="A4" ref-type="aff">4</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Kulisevsky</surname>
<given-names>J</given-names>
</name>
<xref rid="A5" ref-type="aff">5</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Mollenhauer</surname>
<given-names>B</given-names>
</name>
<xref rid="A6" ref-type="aff">6</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Rodriguez-Oroz</surname>
<given-names>MC</given-names>
</name>
<xref rid="A7" ref-type="aff">7</xref>
<xref rid="FN1" ref-type="author-notes">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Tröster</surname>
<given-names>AI</given-names>
</name>
<xref rid="A8" ref-type="aff">8</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Weintraub</surname>
<given-names>D</given-names>
</name>
<xref rid="A9" ref-type="aff">9</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>
Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY, USA and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, KY</aff>
<aff id="A2"><label>2</label>
Centre for Age-Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo</aff>
<aff id="A3"><label>3</label>
Parkinson’s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA</aff>
<aff id="A4"><label>4</label>
Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA</aff>
<aff id="A5"><label>5</label>
Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</aff>
<aff id="A6"><label>6</label>
Paracelsus-Elena-Klinik, Kassel and Georg-August University Goettingen, Germany</aff>
<aff id="A7"><label>7</label>
Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain</aff>
<aff id="A8"><label>8</label>
Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA</aff>
<aff id="A9"><label>9</label>
Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine; Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA</aff>
<author-notes><fn id="FN1" fn-type="present-address"><label>*</label>
<p>Current address: Department of Neurology, Hospital Donostia and BioDonostia, San Sebastian, Spain.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>16</day>
<month>5</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="epub"><day>9</day>
<month>6</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="ppub"><day>15</day>
<month>8</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>15</day>
<month>8</month>
<year>2012</year>
</pub-date>
<volume>26</volume>
<issue>10</issue>
<fpage>1814</fpage>
<lpage>1824</lpage>
<abstract><sec id="S1"><title>Background</title>
<p id="P1">There is controversy regarding the definition and characteristics of mild cognitive impairment in Parkinson’s disease.</p>
</sec>
<sec id="S2"><title>Objective</title>
<p id="P2">The Movement Disorders Society commissioned a Task Force to critically evaluate the literature and determine the frequency and characteristics of Parkinson’s disease-mild cognitive impairment and its association with dementia.</p>
</sec>
<sec sec-type="methods" id="S3"><title>Methods</title>
<p id="P3">Comprehensive PubMed literature review using systematic inclusion and exclusion criteria.</p>
</sec>
<sec id="S4"><title>Results</title>
<p id="P4">A mean of 26.7% (range, 18.9–38.2%) of non-demented Parkinson’s disease patients have mild cognitive impairment. The frequency of Parkinson’s disease mild cognitive impairment increases with age, disease duration, and disease severity. Impairments occur in a range of cognitive domains, but single domain impairment is more common than multiple domain impairment, and within single domain impairment, non-amnestic is more common than amnestic impairment. A high proportion of patients with Parkinson’s disease-mild cognitive impairment progress to dementia in a relatively short period of time.</p>
</sec>
<sec id="S5"><title>Conclusions</title>
<p id="P5">The primary conclusions of the Task Force are that: (1) Parkinson’s disease-mild cognitive impairment is common; (2) there is significant heterogeneity within Parkinson’s disease-mild cognitive impairment in the number and types of cognitive domain impairments; (3) Parkinson’s disease-mild cognitive impairment appears to place patients at risk of progressing to dementia; and (4) formal diagnostic criteria for Parkinson’s disease-mild cognitive impairment are needed.</p>
</sec>
</abstract>
<kwd-group><kwd>mild cognitive impairment</kwd>
<kwd>Parkinson’s disease</kwd>
<kwd>systematic review</kwd>
</kwd-group>
<funding-group><award-group><funding-source country="United States">National Institute on Aging : NIA</funding-source>
<award-id>R01 AG024040-05 || AG</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000181 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000181 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Pmc |étape= Curation |type= RBID |clé= PMC:3181006 |texte= MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:21661055" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |